Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

Cardiomyocyte Impedance Assays

In: Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004.
.
Affiliations
Review

Cardiomyocyte Impedance Assays

Sarah D. Lamore et al.

Excerpt

Cellular impedance assays have been broadly utilized as a label-free approach for toxicity and drug discovery screening. The xCELLigence RTCA Cardio instrument sets itself apart from other impedance technologies by its rapid data acquisition rate (12.9 msec). This speed is fast enough to detect the contractile activity of beating cardiomyocytes, offering a relatively high throughput and robust strategy to noninvasively monitor the effects of test compounds on cardiomyocyte function. This chapter introduces the fundamentals and applications of cardiomyocyte impedance assays. A protocol detailing cardiomyocyte culture, data acquisition, and data analysis using the xCELLigence RTCA Cardio system is provided and considerations for assay design and data interpretation are discussed.

PubMed Disclaimer

References

Literature Cited

    1. Ciambrone, et al. Cellular dielectric spectroscopy: a powerful new approach to label-free cellular analysis. J Biomol Screen. 2004;9(6):467–480. - PubMed
    1. Ramasamy, et al. Drug and bioactive molecule screening based on a bioelectrical impedance cell culture platform. Int J Nanomedicine. 2014;(9):5789–5809. - PMC - PubMed
    1. Peters, et al. Evaluation of cellular impedance measures of cardiomyocyte cultures for drug screening applications. Assay Drug Dev Technol. 2012;10(6):525–532. - PubMed
    1. Xi, et al. Functional cardiotoxicity profiling and screening using the xCELLigence RTCA Cardio System. J Lab Autom. 2011;16(6):415–421. - PubMed
    1. Abassi, et al. Dynamic monitoring of beating periodicity of stem cell-derived cardiomyocytes as a predictive tool for preclinical safety assessment. Br J Pharmacol. 2012;165(5):1424–1441. - PMC - PubMed

Additional References

    1. Lamore, et al. Cellular impedance assays for predictive preclinical drug screening of kinase inhibitor cardiovascular toxicity. Toxicol Sci. 2013;135(2):402–413. - PubMed
    1. Himmel (2013) Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds. J Pharmacol Toxicol Methods 68 (1), 97-111. - PubMed
    1. Jonsson, et al. Impedance-based detection of beating rhythm and proarrhythmic effects of compounds on stem cell-derived cardiomyocytes. Assay Drug Dev Technol. 2011;9(6):589–599. - PMC - PubMed